Halozyme licenses drug delivery technology to Vertex for $15 million
Go back to Halozyme licenses drug delivery technology to Vertex for $15 million| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 69.97 +0.98 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.99 | 52 Week High | $18.39 | |||
| Open | $69.38 | 52 Week Low | $6.96 | |||
| Day High | $70.03 | P/E | N/A | |||
| Day Low | $68.93 | EPS | $-0.58 | |||
| Volume | 217,203 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 467.02 +0.23 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $466.79 | 52 Week High | $134.71 | |||
| Open | $469.67 | 52 Week Low | $73.31 | |||
| Day High | $470.76 | P/E | N/A | |||
| Day Low | $463.76 | EPS | $-1.98 | |||
| Volume | 164,979 | |||||
